Melatonin for Sleep: The Science Behind the Hype
Melatonin appears in everything from bedtime gummies to sprays, patches, and even bath products. Their packaging may promise better sleep, but a product containing melatonin does not automatically treat the reason someone is awake.
The hormone’s clearest role is in timing: it helps signal night to the body. A supplement may be useful when sleep timing is out of sync, such as with jet lag. For persistent insomnia, the evidence is less convincing. The dose, timing, and formulation also matter more than whether the label says “sleep.”
What does melatonin actually do?
Melatonin is a hormone produced by the brain’s pineal gland. Its release normally rises in darkness and helps coordinate the body’s sleep–wake rhythm. Light, especially at the wrong time of day, can shift that signal. Taking melatonin adds a timing cue; it does not switch off wakefulness like a conventional sedative.
That distinction helps explain why melatonin might be more useful for jet lag or a delayed sleep schedule than for waking repeatedly because of pain, stress, or another cause. The same complaint—“I can’t sleep”—can have very different underlying reasons.
How long does it take melatonin to work?
For an immediate-release oral product, a reasonable expectation is roughly 30 to 60 minutes, though the response varies. A systematic review of human pharmacokinetic studies found that blood levels of immediate-release melatonin peaked about 50 minutes after a dose. Peak blood concentration is not the exact moment a person will fall asleep: the body’s clock, light exposure, dose, and individual metabolism also affect the experience.
Extended-release products release melatonin over a longer period, so the same clock does not apply. Nor can timing measured for a tablet simply be transferred to a spray or patch. In particular, the best timing for shifting a circadian rhythm may differ from taking a product shortly before bed; people using melatonin for a diagnosed sleep-timing disorder need advice tailored to that goal.
Does melatonin improve sleep?
The answer depends on the sleep problem. The National Center for Complementary and Integrative Health reports that melatonin can help with jet lag and may help some people with delayed sleep–wake phase disorder. These uses fit its role in adjusting sleep timing.
For insomnia, trial results show smaller benefits than the marketing often implies. A 2013 meta-analysis of 19 trials involving 1,683 people with primary sleep disorders found that participants taking melatonin fell asleep about seven minutes sooner on average than those taking a placebo. The pooled studies included different sleep disorders and ages, so that figure should not be read as a promise for any one person or product.
The American Academy of Sleep Medicine suggests that clinicians not use melatonin to treat chronic sleep-onset or sleep-maintenance insomnia in adults. This is a weak recommendation based on limited evidence, not a claim that melatonin never helps anyone. For persistent insomnia, cognitive behavioral therapy for insomnia (CBT-I) has stronger guideline support.
Are melatonin gummies, sprays, and patches different?
A gummy is a way to take melatonin, not evidence that it works better than a tablet. A spray may be swallowed or absorbed partly through the tissues under the tongue, depending on its instructions and formulation. Small pharmacokinetic studies show that delivery methods can change how quickly melatonin reaches the blood, but that alone does not prove one retail product improves sleep more than another.
Patches aim to deliver melatonin through the skin over time. Experimental patches have been studied in small, specific settings, but those findings do not establish that every consumer patch treats ordinary insomnia. A melatonin-containing bath product presents a different question again: the presence of an ingredient in bathwater does not establish an effective dose or a sleep benefit. Claims about a spray, patch, lotion, or bath need evidence for that product and route, not merely evidence that oral melatonin can affect sleep.
Can you trust the dose on a melatonin gummy label?
A label is not always a precise measure of what a gummy contains. In a 2023 laboratory analysis of 25 melatonin gummy products sold in the United States, only three contained melatonin within 10% of the labeled amount. Among products with detectable melatonin, the measured amount ranged from 74% to 347% of the label claim. This was a sample of products, not a test of every brand or every production batch.
In the United States, melatonin products sold as dietary supplements do not undergo the same premarket approval for safety and effectiveness as drugs. A higher listed dose also should not be assumed to deliver better sleep; the product’s actual contents, release pattern, and reason for use all matter.
What about sleep aids without melatonin?
“Melatonin-free” tells you only what a product leaves out. Sleep gummies without melatonin may contain magnesium, herbs, amino acids, or other ingredients, but their benefits and risks have to be assessed individually. The word “natural” is not evidence that a blend treats insomnia, and a study of one ingredient cannot automatically validate a multi-ingredient gummy.
A sleep aid without melatonin may make sense for someone who does not want that hormone, but it is worth asking what problem the product claims to solve. If difficulty sleeping is frequent or persistent, assessing the cause and considering CBT-I is better supported than repeatedly changing supplements.
What are the safety considerations?
Short-term melatonin use appears safe for most adults in studies, but the long-term effects are less certain. Reported side effects include daytime sleepiness, headache, dizziness, and nausea. People who take medications—particularly blood thinners—or who have epilepsy should check with a healthcare professional before using it. Evidence on use during pregnancy and breastfeeding is limited.
Gummies also need to be kept out of children’s reach and sight. U.S. surveillance data estimated about 11,000 emergency department visits for unsupervised melatonin ingestion among children aged five or younger from 2019 through 2022; many documented exposures involved flavored products. A child’s sleep difficulty should be discussed with a healthcare professional rather than treated on the basis of an adult product label.
The verdict
Melatonin can be useful when the issue is sleep timing, especially jet lag, but it is not a universal sleep remedy. Immediate-release oral melatonin typically reaches peak blood levels in about 50 minutes; that does not guarantee sleep within an hour. Its average effect on falling asleep in mixed sleep-disorder trials was modest, and guidelines do not recommend it as a treatment for chronic insomnia in adults.
Gummies, sprays, patches, and melatonin-free products each make separate claims that need separate evidence. The most useful question is not which bedtime format looks appealing, but whether its ingredients and timing address the sleep problem at hand.
References
- National Center for Complementary and Integrative Health. Melatonin: What You Need To Know. https://www.nccih.nih.gov/health/melatonin-what-you-need-to-know
- Harpsøe NG, Andersen LPH, Gögenur I, Rosenberg J. Clinical pharmacokinetics of melatonin: a systematic review. Clinical Pharmacokinetics. 2015. https://pubmed.ncbi.nlm.nih.gov/26008214/
- Moroni I, Garcia-Bennett A, Chapman J, et al. Pharmacokinetics of exogenous melatonin in relation to formulation, and effects on sleep: a systematic review. Sleep Medicine Reviews. 2021;57:101431. https://pubmed.ncbi.nlm.nih.gov/33549911/
- Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLOS ONE. 2013;8(5):e63773. doi:10.1371/journal.pone.0063773. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0063773
- Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults. Journal of Clinical Sleep Medicine. 2017;13(2):307–349. doi:10.5664/jcsm.6470. https://pmc.ncbi.nlm.nih.gov/articles/PMC5263087/
- Edinger JD, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2021;17(2):255–262. doi:10.5664/jcsm.8986. https://pubmed.ncbi.nlm.nih.gov/33164742/
- Aeschbach D, et al. Use of transdermal melatonin delivery to improve sleep maintenance during daytime. Clinical Pharmacology & Therapeutics. 2009;86(4):378–382. doi:10.1038/clpt.2009.109. https://pubmed.ncbi.nlm.nih.gov/19606092/
- Ponce C, et al. Impact of an over-the-counter “sleep lotion” on human salivary melatonin levels and sleep quality: a randomized controlled trial. Neuroendocrinology Letters. 2024;45(3):167–172. https://pubmed.ncbi.nlm.nih.gov/39146562/
- Cohen PA, et al. Quantity of melatonin and CBD in melatonin gummies sold in the US. JAMA. 2023;329(16):1401–1402. doi:10.1001/jama.2023.2296. https://jamanetwork.com/journals/jama/fullarticle/2804077
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements. https://www.fda.gov/food/information-consumers-using-dietary-supplements/questions-and-answers-dietary-supplements
- Centers for Disease Control and Prevention. Emergency Department Visits for Unsupervised Pediatric Melatonin Ingestion — United States, 2019–2022. MMWR. 2024. https://www.cdc.gov/mmwr/volumes/73/wr/mm7309a5.htm
